Get started
Author

David MacLean

Observed names: DJ. MacLean, David J. MacLean
ORCID: 0000-0003-4932-2839
Observed ORCID: 0000-0003-4932-2839
OpenAlex ID: A5079150668
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
2025 · Caleb Cheng, Jing Hu, et al. · Nature · 64
The effects of radiation therapy on the macrophage response in cancer
2022 · Callum Beach, David MacLean, et al. · Frontiers in Oncology · 47
PDF
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1
2023 · Callum Beach, David MacLean, et al. · Journal of Clinical Investigation · 36
PDF
UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironment
2025 · Tatsuya Suwa, Kelly SW. Lee, et al. · Cell Death and Disease · 6
PDF
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1
2024 · Callum Beach, David MacLean, et al. · Journal of Clinical Investigation · 4
PDF
Innate immune receptor C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy in tumours with immunosuppressive microenvironments
2023 · Callum Beach, David MacLean, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinoma
2025 · D. Majorova, R. Samuel, et al. · Radiotherapy and Oncology
PDF
UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironment by regulating tumour cell fate
2024 · Tatsuya Suwa, Kelly Lee, et al. · bioRxiv (Cold Spring Harbor Laboratory)
665: Targeting C5aR1 to improve radiotherapy in tumours with immunosuppressive microenvironments
2024 · Callum Beach, David MacLean, et al. · Radiotherapy and Oncology
Works count: 9
Citation count: 158
H-index: 4
I10-index: 3
Year
Topic
Type